Changes in γ-secretase activity and specificity caused by the introduction of consensus aspartyl protease active motif in Presenilin 1

Molecular Neurodegeneration

Volumn 3, Issue 1, 2008, Pages

  Carter, Donald B ^a   Dunn, Edwige ^a   Pauley, Adele M ^a   McKinley, Denise D ^a   Fleck, Timothy J ^a   Ellerbrook, Brenda R ^a   Stratman, Nancy C ^a   Zhou, Xiangdong ^b   Himes, Carol S ^a   Nye, Jeffrey S ^a   Tomasselli, Alfredo ^a   Yan, Riqiang ^a,b  

^a PFIZER INC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 44449113772     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-3-6     Document Type: Article

References (64)

1. Amyloidogenesis in Alzheimer's disease: basic biology and animal models. SS Sisodia DL Price, Curr Opin Neurobiol 1992 2 648 52 10.1016/0959-4388(92) 90033-H 1422121
2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. J Hardy DJ Selkoe, Science 2002 297 353 6 10.1126/science.1072994 12130773
3. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. RE Tanzi L Bertram, Cell 2005 120 545 55 10.1016/j.cell.2005.02.008 15734686
4. Presenilin: running with scissors in the membrane. DJ Selkoe MS Wolfe, Cell 2007 131 215 21 10.1016/j.cell.2007.10.012 17956719
5. Presenilin is required for activity and nuclear access of Notch in Drosophila. G Struhl I Greenwald, Nature 1999 398 522 5 10.1038/19091 10206646
6. Evidence for a physical interaction between presenilin and Notch. WJ Ray M Yao P Nowotny J Mumm W Zhang JY Wu R Kopan AM Goate, Proc Natl Acad Sci USA 1999 96 3263 8 10.1073/pnas.96.6.3263 10077672
7. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. B De Strooper W Annaert P Cupers P Saftig K Craessaerts JS Mumm EH Schroeter V Schrijvers MS Wolfe WJ Ray A Goate R Kopan, Nature 1999 398 518 22 10.1038/19083 10206645
8. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. M Okochi H Steiner A Fukumori H Tanii T Tomita T Tanaka T Iwatsubo T Kudo M Takeda C Haass, EMBO J 2002 21 5408 16 10.1093/emboj/cdf541 12374741
9. Uncovering gamma-secretase. H Steiner, Curr Alzheimer Res 2004 1 175 81 10.2174/1567205043332081 15975065
10. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. S Lammich M Okochi M Takeda C Kaether A Capell AK Zimmer D Edbauer J Walter H Steiner C Haass, J Biol Chem 2002 277 44754 9 10.1074/jbc.M206872200 12223485
11. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. P May YK Reddy J Herz, J Biol Chem 2002 277 18736 43 10.1074/jbc.M201979200 11907044
12. Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4. HJ Lee KM Jung YZ Huang LB Bennett JS Lee L Mei TW Kim, J Biol Chem 2002 277 6318 23 10.1074/jbc.M110371200 11741961
13. Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/gamma-secretase-like cleavage. DY Kim LA Ingano DM Kovacs, J Biol Chem 2002 277 49976 81 10.1074/jbc.M210179200 12376527
14. A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. P Marambaud J Shioi G Serban A Georgakopoulos S Sarner V Nagy L Baki P Wen S Efthimiopoulos Z Shao T Wisniewski NK Robakis, EMBO J 2002 21 1948 56 10.1093/emboj/21.8.1948 11953314
15. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gamma-secretase and release signaling fragments. MJ LaVoie DJ Selkoe, J Biol Chem 2003 278 34427 37 10.1074/jbc.M302659200 12826675
16. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage. T Ikeuchi SS Sisodia, J Biol Chem 2003 278 7751 4 10.1074/jbc.C200711200 12551931
17. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. G Yu M Nishimura S Arawaka D Levitan L Zhang A Tandon YQ Song E Rogaeva F Chen T Kawarai A Supala L Levesque H Yu DS Yang E Holmes P Milman Y Liang DM Zhang DH Xu C Sato E Rogaev M Smith C Janus Y Zhang R Aebersold LS Farrer S Sorbi A Bruni P Fraser P St George-Hyslop, Nature 2000 407 48 54 10.1038/35024009 10993067
18. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. R Francis G McGrath J Zhang DA Ruddy M Sym J Apfeld M Nicoll M Maxwell B Hai MC Ellis AL Parks W Xu J Li M Gurney RL Myers CS Himes R Hiebsch C Ruble JS Nye D Curtis, Dev Cell 2002 3 85 97 10.1016/S1534-5807(02)00189-2 12110170
19. Increased amyloid-beta42 43 in brains of mice expressing mutant presenilin 1. K Duff C Eckman C Zehr X Yu CM Prada J Perez-tur M Hutton L Buee Y Harigaya D Yager D Morgan MN Gordon L Holcomb L Refolo B Zenk J Hardy S Younkin, Nature 1996 383 710 3 10.1038/383710a0 8878479
20. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. DR Borchelt G Thinakaran CB Eckman MK Lee F Davenport T Ratovitsky CM Prada G Kim S Seekins D Yager HH Slunt R Wang M Seeger AI Levey SE Gandy NG Copeland NA Jenkins DL Price SG Younkin SS Sisodia, Neuron 1996 17 1005 13 10.1016/S0896-6273(00)80230-5 8938131
21. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. T Tomita K Maruyama TC Saido H Kume K Shinozaki S Tokuhiro A Capell J Walter J Grünberg C Haass T Iwatsubo K Obata, Proc Natl Acad Sci USA 1997 94 2025 30 10.1073/pnas.94.5.2025 9050898
22. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. CA Lemere F Lopera KS Kosik CL Lendon J Ossa TC Saido H Yamaguchi A Ruiz A Martinez L Madrigal L Hincapie JC Arango DC Anthony EH Koo AM Goate DJ Selkoe JC Arango, Nat Med 1996 2 1146 50 10.1038/nm1096-1146 8837617
23. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. S Kumar-Singh J Theuns B Van Broeck D Pirici K Vennekens E Corsmit M Cruts B Dermaut R Wang C Van Broeckhoven, Hum Mutat 2006 27 686 95 10.1002/humu.20336 16752394
24. FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta. J Shioi A Georgakopoulos P Mehta Z Kouchi CM Litterst L Baki NK Robakis, J Neurochem 2007 101 674 81 10.1111/j.1471-4159.2006.04391.x 17254019
25. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. B De Strooper P Saftig K Craessaerts H Vanderstichele G Guhde W Annaert K Von Figura F Van Leuven, Nature 1998 391 387 90 10.1038/34910 9450754
26. Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease. MS Wolfe AJ De Los DD Miller W Xia DJ Selkoe, Biochemistry 1999 38 11223 30 10.1021/bi991080q 10471271
27. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. YM Li MT Lai M Xu Q Huang J DiMuzio-Mower MK Sardana XP Shi KC Yin JA Shafer SJ Gardell, Proc Natl Acad Sci USA 2000 97 6138 43 10.1073/pnas.110126897 10801983
28. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. YM Li M Xu MT Lai Q Huang JL Castro J DiMuzio-Mower T Harrison C Lellis A Nadin JG Neduvelil RB Register MK Sardana MS Shearman AL Smith XP Shi KC Yin JA Shafer SJ Gardell, Nature 2000 405 689 94 10.1038/35015085 10864326
29. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. WP Esler WT Kimberly BL Ostaszewski TS Diehl CL Moore JY Tsai T Rahmati W Xia DJ Selkoe MS Wolfe, Nat Cell Biol 2000 2 428 34 10.1038/35017062 10878808
30. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. G Thinakaran DR Borchelt MK Lee HH Slunt L Spitzer G Kim T Ratovitsky F Davenport C Nordstedt M Seeger J Hardy AI Levey SE Gandy NA Jenkins NG Copeland DL Price SS Sisodia, Neuron 1996 17 181 90 10.1016/S0896-6273(00)80291- 3 8755489
31. Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the gamma-secretase complex. A Tolia L Chavez-Gutierrez SB De, J Biol Chem 2006 281 27633 42 10.1074/jbc.M604997200 16844686
32. The gamma-secretase complex: membrane-embedded proteolytic ensemble. MS Wolfe, Biochemistry 2006 45 7931 9 10.1021/bi060799c 16800619
33. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. R Yan MJ Bienkowski ME Shuck H Miao MC Tory AM Pauley JR Brashier NC Stratman WR Mathews AE Buhl DB Carter AG Tomasselli LA Parodi RL Heinrikson ME Gurney, Nature 1999 402 533 7 10.1038/990107 10591213
34. Structure and mechanism of the pepsin-like family of aspartic peptidases. BM Dunn, Chem Rev 2002 102 4431 58 10.1021/cr010167q 12475196
35. Identification of signal peptide peptidase, a presenilin-type aspartic protease. A Weihofen K Binns MK Lemberg K Ashman B Martoglio, Science 2002 296 2215 8 10.1126/science.1070925 12077416
36. Alzheimer disease gamma-secretase: a complex story of GxGD-type presenilin proteases. C Haass H Steiner, Trends Cell Biol 2002 12 556 62 10.1016/S0962-8924(02)02394-2 12495843
37. The initial substrate-binding site of gamma-secretase is located on presenilin near the active site. AY Kornilova F Bihel C Das MS Wolfe, Proc Natl Acad Sci USA 2005 102 3230 5 10.1073/pnas.0407640102 15722417
38. The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase. A Yamasaki S Eimer M Okochi A Smialowska C Kaether R Baumeister C Haass H Steiner, J Neurosci 2006 26 3821 8 10.1523/JNEUROSCI.5354-05.2006 16597736
39. Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. VK Lazarov PC Fraering W Ye MS Wolfe DJ Selkoe H Li, Proc Natl Acad Sci USA 2006 103 6889 94 10.1073/pnas.0602321103 16636269
40. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. D Campion JM Flaman A Brice D Hannequin B Dubois C Martin V Moreau F Charbonnier O Didierjean S Tardieu, Hum Mol Genet 1995 4 2373 7 10.1093/hmg/4.12.2373 8634712
41. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. EA Rogaeva KC Fafel YQ Song H Medeiros C Sato Y Liang E Richard EI Rogaev P Frommelt AD Sadovnick W Meschino K Rockwood MA Boss R Mayeux P St George-Hyslop, Neurology 2001 57 621 5 11524469
42. Processing amyloid precursor protein at the beta-site requires proper orientation to be accessed by BACE1. I Qahwash W He A Tomasselli RF Kletzien R Yan, J Biol Chem 2004 279 39010 6 10.1074/jbc.M407101200 15234966
43. Employing a superior BACE1 cleavage sequence to probe cellular APP processing. AG Tomasselli I Qahwash TL Emmons Y Lu JW Leone JM Lull KF Fok CA Bannow CW Smith MJ Bienkowski RL Heinrikson R Yan, J Neurochem 2003 84 1006 17 10.1046/j.1471-4159.2003.01597.x 12603825
44. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. W He Y Lu I Qahwash XY Hu A Chang R Yan, Nat Med 2004 10 959 65 10.1038/nm1088 15286784
45. Complete mutagenesis of the HIV-1 protease. DD Loeb R Swanstrom L Everitt M Manchester SE Stamper CA Hutchison III, Nature 1989 340 397 400 10.1038/340397a0 2666861
46. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. MS Shearman D Beher EE Clarke HD Lewis T Harrison P Hunt A Nadin AL Smith G Stevenson JL Castro, Biochemistry 2000 39 8698 704 10.1021/bi0005456 10913280
47. Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease. GM Rishton DM Retz PA Tempest J Novotny S Kahn JJ Treanor JD Lile M Citron, J Med Chem 2000 43 2297 9 10.1021/jm990622z 10882355
48. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. S Weggen JL Eriksen P Das SA Sagi R Wang CU Pietrzik KA Findlay TE Smith MP Murphy T Bulter DE Kang N Marquez-Sterling TE Golde EH Koo, Nature 2001 414 212 6 10.1038/35102591 11700559
49. The Notch pathway: democracy and aristocracy in the selection of cell fate. R Kopan DL Turner, Curr Opin Neurobiol 1996 6 594 601 10.1016/S0959- 4388(96)80090-0 8937822
50. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. EH Schroeter JA Kisslinger R Kopan, Nature 1998 393 382 6 10.1038/30756 9620803
51. Human beta-secretase (BACE) and BACE inhibitors. V John JP Beck MJ Bienkowski S Sinha RL Heinrikson, J Med Chem 2003 46 4625 30 10.1021/jm030247h 14561080
52. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. H Steiner M Kostka H Romig G Basset B Pesold J Hardy A Capell L Meyn ML Grim R Baumeister K Fechteler C Haass, Nat Cell Biol 2000 2 848 51 10.1038/35041097 11056541
53. The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms. X Xia P Wang X Sun S Soriano WK Shum H Yamaguchi ME Trumbauer A Takashima EH Koo H Zheng, Proc Natl Acad Sci USA 2002 99 8760 5 10.1073/pnas.132045399 12070348
54. Rank-order of potencies for inhibition of the secretion of abeta40 and abeta42 suggests that both are generated by a single gamma-secretase. JT Durkin S Murthy EJ Husten SP Trusko MJ Savage DP Rotella BD Greenberg R Siman, J Biol Chem 1999 274 20499 504 10.1074/jbc.274.29.20499 10400678
55. Peptidomimetic probes and molecular modeling suggest that Alzheimer's gamma-secretase is an intramembrane-cleaving aspartyl protease. MS Wolfe W Xia CL Moore DD Leatherwood B Ostaszewski T Rahmati IO Donkor DJ Selkoe, Biochemistry 1999 38 4720 7 10.1021/bi982562p 10200159
56. Presenilin 1 regulates pharmacologically distinct gamma -secretase activities. Implications for the role of presenilin in gamma -secretase cleavage. MP Murphy SN Uljon PE Fraser A Fauq HA Lookingbill KA Findlay TE Smith PA Lewis DC McLendon R Wang TE Golde, J Biol Chem 2000 275 26277 84 10.1074/jbc.M002812200 10816583
57. Biochemical characterization of the gamma-secretase activity that produces beta-amyloid peptides. L Zhang L Song G Terracina Y Liu B Pramanik E Parker, Biochemistry 2001 40 5049 55 10.1021/bi0028800 11305921
58. Active gamma-secretase complexes contain only one of each component. T Sato TS Diehl S Narayanan S Funamoto Y Ihara B De Strooper H Steiner C Haass MS Wolfe, J Biol Chem 2007 282 33985 93 10.1074/jbc.M705248200 17911105
59. Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation. RM Page K Baumann M Tomioka BI Pérez-Revuelta A Fukumori H Jacobsen A Flohr T Luebbers L Ozmen H Steiner C Haass, J Biol Chem 2008 283 677 83 10.1074/jbc.M708754200 17962197
60. Intra- or intercomplex binding to the gamma-secretase enzyme. A model to differentiate inhibitor classes. EE Clarke I Churcher S Ellis JD Wrigley HD Lewis T Harrison MS Shearman D Beher, J Biol Chem 2006 281 31279 89 10.1074/jbc.M605051200 16899457
61. gamma-Secretase complexes containing N- and C-terminal fragments of different presenilin origin retain normal gamma-secretase activity. K Strömberg EM Hansson H Laudon S Bergstedt J Näslund J Lundkvist U Lendahl, J Neurochem 2005 95 3 880 90 16135086 10.1111/j.1471-4159.2005.03415.x
62. The transmembrane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. R Yan P Han H Miao P Greengard H Xu, J Biol Chem 2001 276 36788 96 10.1074/jbc.M104350200 11466313
63. The membrane topology of RTN3 and its effect on binding of RTN3 to BACE1. W He Q Shi X Hu R Yan, J Biol Chem 2007 282 29144 51 10.1074/jbc.M704181200 17699523
64. Identification of a mutant amyloid peptide that predominantly forms neurotoxic protofibrillar aggregates. I Qahwash KL Weiland Y Lu RW Sarver RF Kletzien R Yan, J Biol Chem 2003 278 23187 95 10.1074/jbc.M213298200 12684519